Skip to main content

HSG — Portfolio, Page 9

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

554
Companies
$25.5B
Total invested
$61.5M
Avg. check
60
Industries
Biotechnology 6Artificial Intelligence (AI) 5Pharmaceutical 3Information Technology 3Medical 3Manufacturing 3+54 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 193216 of 554
RootPath
April 2025

RootPath is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.

Biotechnology · Cambridge$1.4M Series Unknown
Cero Therapeutics
April 2025

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

Biotechnology · South San Francisco$8.0M Post Ipo Equity
UXLINK
April 2025

UXLINK is a social infrastructure comprised of social protocols and a collection of Dapps.

Decentralized Finance (DeFi) · SingaporeSeed
Dizal Pharma
April 2025

Dizal Pharma is a biotechnology company that conducts research for the treatment of cancer and immunological diseases.

Biotechnology · Shanghai$246.2M Post Ipo Equity
Boundary Intelligent Control
April 2025

Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft.

Air Transportation · Shenzhen$6.9M Series A
Narwal Robotics
April 2025

Narwal Robotics focus on design, development, and production of intelligent cleaning robots.

CleanTech · Dongguan$100.0M Series E
Insilico Medicine
March 2025

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Artificial Intelligence (AI) · Cambridge$123.0M Series E
Oxford Science Enterprises
March 2025

Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI & software, and deep tech.

Asset Management · Oxford$19.4M Series B
Evolyzer
March 2025

Evolyzer is a synthetic biology technology start-up that specializes in the biomanufacturing of chemicals, agriculture, and medicine.

Biomass Energy · BeijingSeries A
Danking Pharmaceuticals
March 2025

Danatlas is a drug research and development company.

Biopharma · Beijing$20.6M Seed
Geneus
March 2025

Geneus is a developer of gene sequencers and reagents.

Application Specific Integrated Circuit (ASIC) · Chengdu$13.7M Series B
New Vision Medical
February 2025

New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.

Information Technology · HangzhouSeries A
Juhe Youcai
February 2025

Juhe Youcai is a service provider specializing in the digital transformation and enhancement of national credit systems.

Credit$2.0M Seed
Solo AI
February 2025

SoloAI is an innovative AI-powered music creation platform.

Artificial Intelligence (AI)$2.0M Seed
Klook
February 2025

Klook is a travel and leisure booking platform designed to connect travelers with experiences and attractions.

Adventure Travel · Singapore$100.0M Series F
Alternative Bio
February 2025

Alternative Bio is a biotechnology company focused on developing novel therapeutics targeting a post-translational modifying enzymes.

Biotechnology · ChinaCorporate Round
TriClick
February 2025

Builds AI tools that support specific tasks in clinical trial planning and execution.

Generative AI · Boston$7.5M Seed
Bibost Automotive Electronics
January 2025

Bibost Automotive Electronics is a provider of automotive electronic products.

Automotive · Fengtai$40.9M Series B
SoSoValue
January 2025

SoSoValue is an AI-driven investment research platform that provides live crypto prices, on-chain data, and a real-time news feed.

Artificial Intelligence (AI) · Singapore$15.0M Series A
Hejian
January 2025

Hejian is a technology company engaged in providing industrial software and solutions for semiconductor chip companies.

Electronic Design Automation (EDA) · Shanghai$136.5M Series A
Bit Intelligence
January 2025

Bit Intelligence is committed to solving the network scalability and communication efficiency problems faced by artificial intelligence.

Artificial Intelligence (AI) · Haidian$68.3M Angel
Chasing Light Technology
December 2024

Chasing Light is a manufacturing firm that specializes in organic semiconductor photovoltaic technology.

Electronics · Guangzhou$13.7M Series A
Supreium
December 2024

Supreium focuses on the research and application of computer-aided engineering and intelligent industrial design.

Cloud Computing · HaidianSeries B
Jiuxiaoer
December 2024

Jiuxiaoer is an internet enterprise that develops and operates retail brands of alcohol.

Consumer · NanningSeries Unknown

Where HSG invests

Biotechnology6
Artificial Intelligence (AI)5
Pharmaceutical3
Information Technology3
Medical3
Manufacturing3

About HSG's portfolio

How many companies has HSG invested in?

HSG has invested in 554 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does HSG invest in?

HSG's top investment sectors include Biotechnology, Artificial Intelligence (AI), Pharmaceutical, Information Technology, Medical. The firm invests across 60 different industry categories.

What is HSG's largest investment?

Among tracked funding rounds, Dizal Pharma received $246.2M in a Post Ipo Equity round. HSG's total known invested capital is $25.5B.

What is the average investment size for HSG?

HSG's average investment size is $61.5M across its portfolio of 554 companies.

What are HSG's most recent investments?

Recent HSG portfolio additions include RootPath, Cero Therapeutics, UXLINK, Dizal Pharma, Boundary Intelligent Control. These companies were founded in 2020 or later.

Reach the founders behind these 554 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →